Searched for
INDOCO REMEDIES SHARES
Ahead of Market: 10 things that will decide stock market action on MondayDomestic equity benchmarks ended sharply lower on Friday amid rising geopolitical tensions between the US and Iran, rupee weakness and heav...- Buy Indoco Remedies, target price Rs 385: Prabhudas LilladherIndoco Remedies Ltd., incorporated in the year 1947, is a Small Cap company (having a market cap of Rs 3128.50 Crore) operating in Pharmace...
- Indoco Remedies gets EU-GMP certification for Himachal plantIndoco Remedies on Friday said it has received the EU GMP certification for its manufacturing site located in Himachal Pradesh. The company...
- Buy Indoco Remedies, target price Rs 510: ICICI DirectIndoco Remedies Ltd., incorporated in the year 1947, is a Small Cap company (having a market cap of Rs 3507.24 Crore) operating in Pharmace...
- Buy Indoco Remedies, target price Rs 500: Yes SecuritiesPromoters held 58.69 per cent stake in the company as of 31-Mar-2022, while FIIs owned 1.15 per cent, DIIs 18.28 per cent.
- Indoco Remedies hits upper circuit after strong Q1 numbersShares of Indoco Remedies have delivered over more than 100 per cent return in the last one year. The pharma counter has gained about 12 pe...
- Indoco Remedies wins tenders worth Rs 140 crore for supply of kidney stones treatment drug in GermanyAditi Kare Panandikar, Managing Director - Indoco Remedies said: "This is Indoco's first own label product in Europe. Germany is totally te...
- Indoco Remedies gets USFDA nod for schizophrenia, bipolar disorder treatment drugIn a BSE filing, Indoco Remedies announced receipt of approval for its abbreviated new drug application (ANDA) for Olanzapine Tablets USP i...
- Indoco Remedies gets 2 observations from UK health regulator for its Goa facilityThe inspection by UK health regulator, MHRA were held from September 16-20, 2019 and resulted in 2 observations, Indoco Remedies said in a ...
- UK regulator reinstates full GMP status of Indoco Remedies Goa facilityWith this development, the company's operations in Europe will now take off on a fast-track, Indoco Remedies MD Aditi Panandikar said.
- Indoco Remedies gets EIR from USFDA for 2 plants in Goa"We are happy to receive the EIR in less than two months from the date of inspection," Indoco Remedies MD Aditi Kare Panandikar said.
- Buy Indoco Remedies, target Rs 198: Anand RathiIndoco Remedies is a smallcap company, operating in pharmaceuticals and health care sector.
- USFDA retains OAI status for Indoco's Goa plantThe facility was inspected by the USFDA in January 2019.
- Top gainers of Thursday's afternoon sessionIn the Nifty50 index, 14 stocks were trading in the green, while 35 stocks were in the red.
- Hold Indoco Remedies, target Rs 190: ICICI DirectHold Indoco Remedies Ltd. at a price target of Rs 190.0 .
- Indoco Remedies Q4 net profit down 14 pc at Rs 18 crShares of Indoco Remedies were trading at Rs 191, down 0.49 per cent on BSE.
- USFDA issues 6 observations post Indoco's Goa plant inspectionThe United States Food and Drug Administration (USFDA) inspected the company's Goa Plant II from August 31, 2016 to September 4, 2016, Indo...
- Buy Indoco Remedies with a target of Rs 311: Prakash Gaba"Indoco Remedies is a 'BUY' call with a target of Rs 311 and a stop loss of Rs 278."
- Indoco buys La NovaChem unitIndoco Remedies, a Rs 215-crore Mumbai-based pharmaceutical company, has acquired La NovaChem’s active pharmaceutical ingredient (API) manu...
- Indoco Remedies acquires La Nova ChemIndoco Remedies Ltd, a manufacturer and distributor of pharmaceutical products and services, on Tuesday said it has acquired a 100 per cent...
Load More
